The Margaritaville Data Dump

[mrmarket]

Time for another dump...love a bunch in here...which ones do you like??


ABG ACT AER AET AFFX AFOP AFSI AGX AKRX AL ALNE ALXN AMKR AMOT ANIK ARRS ASX AVGO AVIV AXAS BELFB BFR BMA BWA BWFG BWLD BX BXP CAR CAVM CBG CBPO CBT CE CELG CLR CNOB COMM CP CPE CRHVF CSCD CTDH CUBE CVALF CXDC CYT DAVE DDAIF DFT DOW DPS ECOL EDN EMES ENBL ENSG ENSV EQU ESCA ESTE EVDY EXR FANG FB FBIZ FL FLEX GGAL GIII GILD GMK GNW GPK GRFS GSAT GT HCLP HES HGT HIW HNNA HOLI HTA HUN ICON IEX ILMN IQNT ITC ITMN JAZZ JHX KFY KIM KONA KORS KW LAD LCI LDL LENB LM LSCC LUCRF MCO MMP MPWR MTOR MTR MU NDZ NED NHLD NJR NNBR NOC NTL NWPIF OCIR ODFL OILT OME OTEX OVTI PAC PAG PAM PE PFIE PHX PKG PL PNDMF POCEF POL POZN PPC PQ PTSI PXFG PXLW QIWI RESI REX RGEN RMBS RUSHB RVSB SBGL SBNY SHPG SIF SKBI SLCA SLXP SMCI SMP SN SNDK SPG SPIL SPND SSS STV STWD STZ SWHC SWKS SXI SYA TEN TMH TPL TRN TROW TSLX UBNT UHAL UIHC UNP UNTY UPMKY USLM VC VDSI VET VIPS VNCE VRX VSEC WAB WCN WLDN WLK WSCI WWWW XEC XRS ZBRA

[drutzen]

Well well well, I was going to start looking, and as MM says it all starts with the charts, so I looked at the first chart, and what a surprise, do I need to go any farther. ABG, great looking chart and Asbury Park, The Boss and Mr. Market, or is Mr. Market the Boss? Forget California Chrome, we have a triple crown here.
I will peruse the others now.

[investorone]

SWKS gets my vote and it's interesting that airlines like LUV are not in the dump--here's a good article I found about SWKS:

http://seekingalpha.com/article/2256233-apple-and-skyworks-are-both-heading-skyward

Question for MM---if a stock (let's say LUV) is not in a dump subsequent to its purchase, wouldn't it follow that it's a sell sign since by not being in the current dump a stock would not be picked? Thanks again for all your dumps etc. as they are great homework for sure!

[mrmarket]

SWKS gets my vote and it's interesting that airlines like LUV are not in the dump. Question for MM---if a stock (let's say LUV) is not in a dump subsequent to its purchase, wouldn't it follow that it's a sell sign since by not being in the current dump a stock would not be picked? Thanks again for all your dumps etc. as they are great homework for sure!

I try to keep the dump to 200 stocks. If it spills over to 200, I prune out the ones I already own.

[toxo]

Most of 'em.

[investorone]

That's interesting as sometimes I find they are and sometimes I find they are not---is that just a function of the "pruning" where some are taken out and you happen to leave some in a new dump by accident, MM?

[mrmarket]

That's interesting as sometimes I find they are and sometimes I find they are not---is that just a function of the "pruning" where some are taken out and you happen to leave some in a new dump by accident, MM?

It's not that scientific.

[tiedyed1]

There are three from this dump that are not in the current MM portfolio I can share my thoughts on:

ODFL: this 80 year old company freight company delivers on every line. Look at the 1 year chart. Look at the 3 year chart. Look at the 5 year chart. 15% business growth and continued optimistic projections. I have no position but wish I did months ago.

CXDC: my one China play I do have a position in. After CXDC made the top 5 a few weeks ago I did my due diligence, commented publicly and I jumped in. I purchased shares on 5/15 at $8.64. It is now trading at $13.00 Yes, up 50% in less than a month. Am I selling? No. Based on everything I have read the top and bottom line should double by the end of this year and the stock has a PE of 6. I feel CXDC easily has another 15% to give.

GILD: I love Biotech. I own and hold them, trade them, write covered calls with those hefty time premiums and just enjoy this whole sector as a big part of my portfolio. GILD pulled back today and I bought it today at $78.60. Why?
I have been looking for an entry point in GILD for a couple of weeks now after drinking some Margartita's (seriously) with an old college buddy of mine who has been an executive in big pharma for 30 years. He was talking about the singular mind blowing event in big pharma history with Gilead coming up with a CURE for Hep C. For decades we have been hearing about biotechs and the amazing leaps they have accomplished...headlines talking about a new cancer drug that can extend life by a year or so, or a new treatment for some disease, here we have a CURE that eradicates Hepatitis C and they are working on the other ones.

Now, Gilead is not the only player with a Hep C drug. Merck bought Idenix today for 3.85B for their Hep C drug. That is why GILD went down today; because headlines reflecting competition... BUT the competition is years away from ringing their registers and GILD is the leader here right now making history. Congress piped up a couple of months ago questioning how GILD can charge $80,000 for their treatment to eradicate Hep C and the stock tumbled in fear...however, it has bounced back and now that immediate reactions have settled down it is coming to light that an $80,000 solution to eradicate a disease is much cheaper than the hundreds of thousands of dollars to treat the effects of Hep C over years and years of its debilitating effects. I am no doctor. I am no scientist. But GILD has this drug, which in the first quarter saw $2.3B in Hep C revenue is just getting started. Health insurers initially balked but to what extent? Studies are now showing it will save them money by spending the $ up front to eradicate the disease. This is historic and no one was prepared for this matrix in their calculations, but it is real and happening.

Anyway, I bought today and see it will have no problem reaching +15% this year.

I really have no idea if any of these should be in the top 5, but, as usual, just adding my .02
Thanks;
-Adam
Old Hippy & Mortgage Pro

[mrmarket]

There are three from this dump that are not in the current MM portfolio I can share my thoughts on:

ODFL: this 80 year old company freight company delivers on every line. Look at the 1 year chart. Look at the 3 year chart. Look at the 5 year chart. 15% business growth and continued optimistic projections. I have no position but wish I did months ago.

CXDC: my one China play I do have a position in. After CXDC made the top 5 a few weeks ago I did my due diligence, commented publicly and I jumped in. I purchased shares on 5/15 at $8.64. It is now trading at $13.00 Yes, up 50% in less than a month. Am I selling? No. Based on everything I have read the top and bottom line should double by the end of this year and the stock has a PE of 6. I feel CXDC easily has another 15% to give.

GILD: I love Biotech. I own and hold them, trade them, write covered calls with those hefty time premiums and just enjoy this whole sector as a big part of my portfolio. GILD pulled back today and I bought it today at $78.60. Why?
I have been looking for an entry point in GILD for a couple of weeks now after drinking some Margartita's (seriously) with an old college buddy of mine who has been an executive in big pharma for 30 years. He was talking about the singular mind blowing event in big pharma history with Gilead coming up with a CURE for Hep C. For decades we have been hearing about biotechs and the amazing leaps they have accomplished...headlines talking about a new cancer drug that can extend life by a year or so, or a new treatment for some disease, here we have a CURE that eradicates Hepatitis C and they are working on the other ones.

Now, Gilead is not the only player with a Hep C drug. Merck bought Idenix today for 3.85B for their Hep C drug. That is why GILD went down today; because headlines reflecting competition... BUT the competition is years away from ringing their registers and GILD is the leader here right now making history. Congress piped up a couple of months ago questioning how GILD can charge $80,000 for their treatment to eradicate Hep C and the stock tumbled in fear...however, it has bounced back and now that immediate reactions have settled down it is coming to light that an $80,000 solution to eradicate a disease is much cheaper than the hundreds of thousands of dollars to treat the effects of Hep C over years and years of its debilitating effects. I am no doctor. I am no scientist. But GILD has this drug, which in the first quarter saw $2.3B in Hep C revenue is just getting started. Health insurers initially balked but to what extent? Studies are now showing it will save them money by spending the $ up front to eradicate the disease. This is historic and no one was prepared for this matrix in their calculations, but it is real and happening.

Anyway, I bought today and see it will have no problem reaching +15% this year.

I really have no idea if any of these should be in the top 5, but, as usual, just adding my .02
Thanks;
-Adam
Old Hippy & Mortgage Pro

Adam...you should start your own thread. Your analysis is excellent.

[jiesen]

There are three from this dump that are not in the current MM portfolio I can share my thoughts on:

ODFL: this 80 year old company freight company delivers on every line. Look at the 1 year chart. Look at the 3 year chart. Look at the 5 year chart. 15% business growth and continued optimistic projections. I have no position but wish I did months ago.

I really have no idea if any of these should be in the top 5, but, as usual, just adding my .02
Thanks;
-Adam
Old Hippy & Mortgage Pro

Holy crap that chart on ODFL is a straight line to heaven:

https://finance.yahoo.com/q/bc?s=ODFL+Basic+Chart&t=5y

[M0n3y]

Still a bit reluctant to buy more Chinese companies but I've to admit that CXDC looks extremely well...